Abilities
Industries
Vietnam
About
Insights
Need Advisory?
Every engagement begins with a structured conversation about your situation.
Contact Us →Every engagement begins with a structured conversation about your situation.
Contact Us →Supporting healthcare investment and pharmaceutical market entry
Vietnam's healthcare sector is undergoing rapid modernisation, with significant demand for imported pharmaceuticals, medical devices, and private hospital investment. The pharmaceutical market is projected to reach $10 billion by 2030. We assist pharmaceutical companies with drug registration through the Drug Administration of Vietnam, medical device classification and import licensing, hospital investment structuring, and IP protection for pharmaceutical patents and trademarks.
Vietnam's healthcare sector is at the forefront of a transformative period, characterized by a burgeoning middle class and an aging population. This demographic shift is fueling a surge in demand for advanced healthcare services and pharmaceuticals. The country's healthcare expenditure is expected to increase significantly, with a growing emphasis on preventative care and chronic disease management. The pharmaceutical market, in particular, is anticipated to experience robust growth, driven by the need for more sophisticated treatments and a greater focus on public health.
The Vietnamese government has been actively investing in healthcare infrastructure, which has opened avenues for foreign pharmaceutical companies to enter the market. Additionally, the increasing prevalence of non-communicable diseases, such as diabetes and cardiovascular conditions, has created a substantial market for specialized medications.
Investment in Vietnam's healthcare and pharmaceutical sector presents a lucrative opportunity for both local and international players. The private hospital sector is particularly attractive, with a growing demand for high-quality healthcare services. Foreign investors are increasingly looking to establish joint ventures or wholly-owned subsidiaries to tap into this market. Additionally, the production and distribution of generic drugs offer a cost-effective entry point for pharmaceutical companies seeking to expand their footprint in the region.
The Vietnamese government's commitment to improving healthcare access and quality has led to the creation of various incentives for investors. These include tax breaks and streamlined regulatory processes, which are particularly beneficial for companies involved in the research and development of new drugs and medical devices.
The regulatory environment in Vietnam's healthcare and pharmaceutical sector is governed by the Drug Administration of Vietnam (DAV), which oversees drug registration, quality control, and safety. Companies must navigate a complex set of regulations that require detailed documentation and adherence to international standards. Compliance with these regulations is critical to ensure the safety and efficacy of pharmaceutical products and to maintain a competitive edge in the market.
Investors must also be mindful of intellectual property rights, as the protection of pharmaceutical patents and trademarks is essential to safeguarding investments. The Vietnamese government has been making strides in strengthening its intellectual property laws, aligning with international norms and practices. This development is crucial for fostering an environment conducive to innovation and investment in the healthcare sector.
Looking ahead to 2026, Vietnam's healthcare and pharmaceutical sector is poised for significant growth. The government's continued investment in healthcare infrastructure, coupled with the ongoing modernization of the healthcare system, is expected to create a more robust and efficient market. This will likely lead to increased demand for advanced medical technologies and specialized pharmaceuticals, presenting new opportunities for both domestic and international companies.
Furthermore, the integration of digital technologies, such as telemedicine and electronic health records, is anticipated to revolutionize the delivery of healthcare services. This digital transformation will not only improve patient outcomes but also create new avenues for investment and innovation within the sector. As Vietnam continues to evolve as a regional healthcare hub, the strategic outlook for the healthcare and pharmaceutical industry remains promising.
Every engagement begins with a structured conversation about your situation and how we might help.
Arrange a Consultation
